Biodesix extends its blood-based lung cancer diagnostic portfolio - Boulder Daily Camera

Biodesix extends its blood-based lung cancer diagnostic portfolio  Boulder Daily Camera

Boulder-based Biodesix, Inc. is acquiring a Kansas lab run by Oncimmune Holdings, a global immunodiagnostics group, and is partnering with it to help ...



Comments

Popular posts from this blog

Stage 4 Lung Cancer Life Expectancy

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Free biotech stocks directory, pharma stocks, telemedicine stocks ...